First U.S. availability
OnLife has previously been distributed from Europe. Novilora now brings the product directly to the United States.
Novilora® brings OnLife®—an innovative nutritional supplement developed and produced in Italy—to the United States for the first time.
Previously, U.S. customers could obtain OnLife only by ordering it from Europe, often at a total cost of more than $100 after international shipping and currency conversion. Novilora now makes this important product available directly in the United States.
Initial U.S. inventory is arriving soon. Reserve yours now to be among the first to receive Novilora.

The same product developed and produced in Italy can now be purchased domestically—without the expense and inconvenience of ordering it from Europe.
Same product
OnLife® in Europe
↓
Novilora® in the U.S.
Novilora is the registered U.S. product name for OnLife, a nutritional supplement developed and produced in Italy by an established pharmaceutical and supplement manufacturer.
This is not a newly formulated imitation or substitute. Novilora brings the established OnLife product to U.S. customers under its registered U.S. name.
In Europe
OnLife®
In the U.S.
Novilora®
Same formulation. Same manufacturer. Same published research. New name for domestic access.
A Nutritional Supplement — Not a Prescription Drug
Novilora is a nutritional supplement and does not require a prescription. It is intended to provide nutritional support for people experiencing neuropathy symptoms, including symptoms associated with chemotherapy-induced peripheral neuropathy, commonly called CIPN.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
For many people, polyneuropathy symptoms affect far more than physical comfort. They affect confidence, independence, and quality of life.
Novilora was created to support nerve health and help people move forward.

What makes Novilora meaningful for U.S. customers seeking support for neuropathy symptoms.
OnLife has previously been distributed from Europe. Novilora now brings the product directly to the United States.
The OnLife formulation has been evaluated in published clinical research involving people experiencing symptoms associated with CIPN.
Novilora is a nutritional supplement, not a prescription drug.
The product is manufactured in Italy by an established pharmaceutical and supplement company.
Customers will no longer need to manage European ordering, international shipping, currency conversion, or total costs that have often exceeded $100.
How the formulation supports nerve health
The OnLife formulation behind Novilora has been evaluated in clinical research involving patients experiencing symptoms associated with chemotherapy-induced peripheral neuropathy.
Researchers observed improvements and stabilization of sensory and motor neuropathy symptoms in many patients following three months of use.
View clinical research146
Patients Studied
Peer-reviewed
Published Research
3 months
Evaluation Period
Reported
Patient Improvements
Novilora's fatty acid and PEA combination is formulated to act on several pathways involved in nerve health.

Please note: Consult your healthcare provider regarding your individual medical situation.

Through CaraKit, we have listened to people affected by cancer share the difficult realities that continue beyond treatment. Again and again, we heard about neuropathy—the numbness, tingling, discomfort, and disruption it can bring to everyday life.
We also heard how few meaningful options people felt they had.
When we learned about OnLife and the research behind it, we knew we had to act. Our goal became clear: make this product more accessible to people in the United States, without requiring them to order from Europe or absorb the high cost of international shipping.
That commitment led to Novilora.
Novilora reflects CaraKit's larger mission: listening to the cancer community, recognizing unmet needs, and taking practical steps to help people feel supported during treatment and beyond.

After years of supporting patients through cancer treatment and recovery, we saw firsthand how devastating polyneuropathy symptoms can become — and how few meaningful options exist.
Novilora was inspired by emerging research and created to provide a science-informed approach to supporting nerve health and recovery.
"Recovery is not a destination. It is a path — and people deserve real support along it."
Reserve your order now to be among the first to receive it.
Reserve Your Novilora®Single packages for trying Novilora. The three-pack — our most popular option — offers the best value for a full three-month evaluation.
Single Package

Three Packages

Reservation pricing. Charged at checkout. Initial U.S. inventory arriving soon — cancel anytime before fulfillment.
How people describe their journey with the OnLife formulation. Customer testimonials are individual experiences and are separate from published clinical research.
After chemotherapy my feet burned constantly — I couldn't sleep, couldn't walk far, couldn't feel the ground. Three months into Novilora the burning had eased, the tingling was quieter, and I was walking the dog again in the mornings. It gave me my evenings back.
Margaret H.
Age 62 · 4 months on Novilora · CIPN after breast cancer treatment
“The numbness in my fingertips made buttons and zippers impossible. By the second month I could feel textures again — my grandkids' hair, the seam on a shirt. Small things, but they matter.”
David R.
Age 58 · 3 months on Novilora
“I started Novilora during my last cycles of oxaliplatin on my oncologist's okay. The sharp electric pains that used to wake me up have faded. I'm sleeping through the night for the first time in a year.”
Elena M.
Age 51 · 5 months on Novilora
“I nearly stopped after two weeks because I felt nothing yet — my wife told me to stick with it. By week six the pins-and-needles had softened, and by month three my balance was steadier. Patience paid off.”
Robert K.
Age 67 · 3 months on Novilora
Individual experiences vary. Customer testimonials are not clinical evidence. Novilora is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease.
Novilora® is OnLife®—now in the United States.
Reserve Your Novilora®